Oric Pharmaceuticals, Inc. Common Stock (ORIC) Stock Price
ORICStock
$13.83+38.19%52W
Market Cap$1.43B
P/E—
PEG Ratio—
Div yield—
Beta0.95
ORIC Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)13.04%
Price vs S&P 500 (4W)9.96%
VGM Score69.47
ORIC Earnings Surprise History
Q2 25-0.47est. -0.44
Q3 25-0.33est. -0.40
Q4 25-0.30est. -0.37
Q1 26-0.34est. -0.32
Q2 26-0.38est. -0.36
ORIC Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.33
4.32
4.32
4.33
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ORICOric Pharmaceuticals, Inc. Common Stock | — | — | B | $13.83 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About Oric Pharmaceuticals, Inc. Common Stock
ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies designed to overcome cancer resistance mechanisms across three focus areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company's pipeline includes product candidates ORIC-944, ORIC-114, and ORIC-533.